Medtronic plc. MDT
Medtronic plc is a global leader in medical technology, specializing in the development, manufacturing, and distribution of a wide range of medical devices and therapies. The company serves healthcare providers and patients worldwide by offering innovative solutions across multiple therapeutic areas, including cardiovascular, neuroscience, medical surgical, and diabetes care. Its business model revolves around continuous research and development to create advanced medical technologies, which are then commercialized through a global sales and distribution network to hospitals, clinics, and healthcare systems. Medtronic operates through four main reportable segments: Cardiovascular, Neuroscience, Medical Surgical, and Diabetes. The Cardiovascular segment focuses on cardiac rhythm management, heart failure, structural heart, aortic, coronary, and peripheral vascular products. The Neuroscience segment includes cranial and spinal technologies, specialty therapies, and neuromodulation devices. The Medical Surgical segment provides surgical and endoscopy equipment along with acute care and monitoring solutions. The Diabetes segment offers insulin pumps, continuous glucose monitoring systems, and related diabetes management technologies. The company generates revenue primarily through the sale of its medical devices and associated consumables, with additional income from service contracts, software solutions, and ongoing patient support programs. Medtronic invests significantly in research and development to maintain its competitive edge and drive innovation in medical technology, while also pursuing strategic acquisitions to expand its product portfolio and geographic reach.
LSTM Forecast
Forecast model is not trained yet for this market.
Train and backfill the LSTM forecast to surface a directional view here.